Rich’s experience includes former senior management positions at Meritage Pharma, Sorrento Therapeutics, Elevation Pharmaceuticals, Verus Pharmaceuticals, Women First HealthCare, Elan Pharmaceuticals, Phase Metrics, and Deloitte & Touche LLP, where he specialized in emerging growth and publicly traded companies. Over the past 20 years, Rich has raised over $50 million in venture capital, major commercial banks and institutions, public offering proceeds and from high growth pharmaceutical and biotech companies. Rich has participated in acquisitions and divestitures valued at over $1billion. In 2014, Rich was awarded the public company CFO of the Year in San Diego by the San Diego Business Journal.

‍